- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02354716
EndoFLIP Use in Upper GI Tract Stenosis (EndoFLIP)
September 10, 2019 updated by: University of Pennsylvania
Expanding the Clinical Applications of Functional Luminal Imaging (EndoFLIP) in Esophageal Stenoses
The purpose of this study is to investigate the use of a functional luminal imaging probe to characterize benign esophageal luminal strictures before and after dilation and identify predictors of response to therapy.
Patients will be evaluated during endoscopy using functional luminal imaging (EndoFLIP; Crospon Medical Devices, Galway, Ireland) to characterize the geometry of benign luminal esophageal narrowing before and after dilation.
Study Overview
Status
Terminated
Intervention / Treatment
Detailed Description
To date there is no effective way to objectively characterize and predict response to endoscopic dilation of luminal strictures of the GI tract.
Endoscopic dilation allows effective remediation of benign esophageal and upper GI tract strictures.
Stricture dilation is performed after the stricture diameter is crudely gauged by the endoscopist.
Stricture characteristics are based on the severity of symptoms and appearance.
A stricture may be graded as mild, moderate, severe and as to whether or not the endoscope is able to traverse the luminal narrowing.
By precisely measuring the diameter and length of a stricture, the endoscopist can know exactly what type of dilation is necessary.
Benign esophageal strictures may also be refractory to dilation and thus require multiple sessions, prior to achieving successful remediation.
The purpose of this study is to investigate the use of a functional luminal imaging probe to characterize benign esophageal luminal strictures before and after dilation and identify predictors of response to therapy.
Patients will be evaluated during endoscopy using functional luminal imaging (EndoFLIP; Crospon Medical Devices, Galway, Ireland) to characterize the geometry of benign luminal esophageal narrowing before and after dilation.
The study will include patients with strictures referred for endoscopic dilation for the following indications: radiation induced strictures, peptic strictures, RFA induced strictures, EMR induced strictures, eosinophilic esophagitis, Zenkers diverticulum, and strictures related to surgical anastomoses.
In patients with benign refractory esophageal strictures referred for endoluminal prostheses EndoFLIP will be used to characterize the stricture prior to stent placement.
Study Type
Observational
Enrollment (Actual)
5
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, United States, 19104
- University of Pennsylvania
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 80 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Adult patients with benign refractory esophageal strictures referred for placement of an esophageal stent are eligible for this study.
Description
Inclusion Criteria:
- > or = to 18 years of age
- Referred for evaluation and treatment of benign esophageal luminal narrowing
- Clinical diagnosis of benign esophageal luminal narrowing with documentation and imaging
- Adult patients with benign refractory esophageal strictures referred for placement of an esophageal stent are eligible for this study
- Willing and able to give informed consent
- No condition or comorbidity which would prevent the patient from undergoing a successful upper endoscopy
Exclusion Criteria:
- < 18 years of age
- Pregnancy
- History of prior endoscopic dilation* (*unless referred for placement of stent)
- Coagulopathy
- Inability to traverse the stricture using standard techniques
- Patients unable to provide consent
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Case-Only
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
EndoFLIP Measurements
To define the role of a functional luminal imaging probe (EndoFLIP) in benign upper GI luminal narrowing.
EndoFlip measurement of the cross sectional area of the narrowing will be obtained prior to and after endoscopic dilation.
Patients will follow up for repeat endoscopy and dilation if indicated.
EndoFLIP measurements will be made again before and after dilation.
The use of EndoFlip may offer insight in to the clinical and endoscopic predictors of successful stricture dilation.
|
The Endolumenal Functional Lumenal Imaging Probe Imaging System is a technology developed to measure the dimensions & function of a variety of hollow organs throughout the body.
Since receiving FDA clearance for sale in the United States EndoFLIP has been used in a variety of clinical applications.
We intend to investigate the potential clinical applications of EndoFLIP in the upper GI tract in patients with esophageal stenoses who require endoscopic therapy for benign esophageal strictures.
The use of EndoFLIP to characterize a stricture pre- & post- dilation may offer insight in to the clinical and endoscopic predictors of successful stricture dilation, & what characteristics determine & predict refractory & recurrent strictures.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Collection of Measurements of the Luminal Narrowing Using EndoFlip
Time Frame: 12 Months
|
The study is observational and a proof of concept study.
Measurements of the luminal narrowing using EndoFLIP will be obtained.
|
12 Months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Observation of Pre-Endoscopic Therapy EndoFLIP Measurements
Time Frame: 12 Months
|
Patients will undergo the clinically indicated procedure for benign esophageal luminal narrowing remediation.
Before undergoing clinically indicated esophageal therapy, measurements of the luminal narrowing using EndoFLIP will be obtained to identify potential predictors of response to endoscopic therapy.
These measurements will included luminal diameter, length of narrowing and narrowing distensibility and will be obtained before and after delivery of the clinically indicated endoscopic therapy.
|
12 Months
|
|
Observation of Post-Endoscopic Therapy EndoFLIP Measurements
Time Frame: 12 Months
|
After undergoing clinically indicated esophageal therapy at clinically-indicated follow-up endoscopies, measurements of the luminal narrowing using EndoFLIP will again be obtained to identify responses to endoscopic therapy.
|
12 Months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Vinay Chandrasekhara, MD, University of Pennsylvania
- Principal Investigator: Gregory G Ginsberg, MD, University of Pennsylvania
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
December 1, 2014
Primary Completion (Actual)
January 1, 2019
Study Completion (Actual)
January 1, 2019
Study Registration Dates
First Submitted
December 8, 2014
First Submitted That Met QC Criteria
January 29, 2015
First Posted (Estimate)
February 3, 2015
Study Record Updates
Last Update Posted (Actual)
September 12, 2019
Last Update Submitted That Met QC Criteria
September 10, 2019
Last Verified
September 1, 2019
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Digestive System Diseases
- Immune System Diseases
- Hypersensitivity, Immediate
- Hematologic Diseases
- Gastrointestinal Diseases
- Gastroenteritis
- Pathological Conditions, Anatomical
- Hypersensitivity
- Esophageal Diseases
- Leukocyte Disorders
- Eosinophilia
- Diverticulum, Esophageal
- Constriction, Pathologic
- Eosinophilic Esophagitis
- Esophagitis
- Diverticulum
- Diverticular Diseases
- Esophageal Stenosis
- Zenker Diverticulum
Other Study ID Numbers
- 819014
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Eosinophilic Esophagitis
-
Fondazione IRCCS Policlinico San Matteo di PaviaRecruitingEosinophilic Esophagitis (EoE)Italy
-
University of North Carolina, Chapel HillNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); A...Not yet recruitingEosinophilic Esophagitis | Eosinophilic Esophagitis (EoE) | EoEUnited States
-
Mayo ClinicRecruitingEosinophilic Esophagitis (EoE)United States
-
Kate Farms IncSeattle Children's HospitalRecruitingEosinophilic Esophagitis (EoE)United States
-
Mayo ClinicVanderbilt University Medical CenterEnrolling by invitationComparison of Eohilia With Dupixent on Esophagus Diameter in Patients With Eosinophilic Esophagitis.Eosinophilic Esophagitis (EoE)United States
-
Federico II UniversityRecruitingEsophagitis, EosinophilicItaly
-
Children's Hospital Medical Center, CincinnatiNational Institute of Allergy and Infectious Diseases (NIAID); National Institute... and other collaboratorsCompletedEosinophilic Esophagitis (EoE) | Eosinophilic Gastrointestinal Disorders (EGIDs)United States
-
Shaare Zedek Medical CenterEnrolling by invitationEosinophilic Esophagitis (EoE)Israel
-
Ann & Robert H Lurie Children's Hospital of ChicagoRecruitingEosinophilic Gastroenteritis | Eosinophilic Esophagitis | Eosinophilic Colitis | Eosinophilic Gastrointestinal DiseaseUnited States
-
Children's Hospital of PhiladelphiaRecruitingEosinophilic Esophagitis (EoE)United States
Clinical Trials on EndoFLIP
-
Dr. Wiley ChungMedtronicRecruiting
-
Wake Forest University Health SciencesMedtronicActive, not recruitingHiatal Hernia | Esophagogastric Junction DistensibilityUnited States
-
Temple UniversityUnknownGastroparesisUnited States
-
Chinese University of Hong KongCompletedAsymptomatic Condition | Faecal IncontinenceHong Kong
-
Mayo ClinicRecruitingGastroesophageal Reflux | Sleeve Gastrectomy | Bariatric Surgery ComplicationUnited States
-
Indiana UniversityRecruitingDysphagia, EsophagealUnited States
-
Northwestern UniversityWithdrawn
-
Ohio State UniversityCompleted
-
Indiana UniversityRecruitingEosinophilic EsophagitisUnited States
-
Mayo ClinicCompleted